Trial intelligence / Profile preview

TIPS vs SEMS for Refractory Variceal Bleed in Cirrhosis

NCT03827681Unknown

Sponsor
Institute of Liver and Biliary Sciences
Start
Feb 2019
Primary completion
Jun 2020
Countries
1
01

Overview

Randomised, open-label trial in Liver cirrhosis (LC) and Variceal bleeding (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoints: Survival at 6 weeks and Early Re-bleed at 5 days. Status: unknown.

02

Conditions

Liver cirrhosis (LC)Variceal bleeding

Beyond the preview

Go deeper on NCT03827681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03827681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call